Zobrazeno 1 - 10
of 945
pro vyhledávání: '"Norhammar A"'
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography be
Externí odkaz:
https://doaj.org/article/cf5d95491c654b4586aaaa855a2ac234
Autor:
Johan Sundström, Johan Ärnlöv, Stelios Karayiannides, Johan Bodegard, Karolina Ersmark, Stefan Gustafsson, Thomas Cars, Maria K. Svensson, Anna Norhammar
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1377-1388 (2024)
Abstract Aims This study aimed to characterize a contemporary population with subtypes of incident or prevalent heart failure (HF) based on reduced (HFrEF), mildly reduced, or preserved (HFpEF) left ventricular ejection fraction (LVEF) and to assess
Externí odkaz:
https://doaj.org/article/899c8b0a6e57407cb92948c2e9448a93
Autor:
Alessia Riccio, Elena Fortin, Linda Mellbin, Anna Norhammar, Per Näsman, Lars Rydén, Giorgio Sesti, Giulia Ferrannini
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Females are generally less prone to cardiovascular (CV) events than males, but this protection is trumped by diabetes. The mechanism behind the increased relative risk in females with diabetes is not fully understood. Insulin resi
Externí odkaz:
https://doaj.org/article/29b19a77abd648ce98b2f8cec2dd5c7e
Publikováno v:
In Journal of Endodontics August 2024 50(8):1073-1081
Autor:
Santos-Pardo, Irene, Andersson Franko, Mikael, Lagerqvist, Bo, Ritsinger, Viveca, Eliasson, Björn, Witt, Nils, Norhammar, Anna, Nyström, Thomas
Publikováno v:
In Journal of the American College of Cardiology 16 July 2024 84(3):260-272
Autor:
Johan Ärnlöv, Johan Bodegård, Johan Sundström, Thomas Cars, Stelios Karayiannides, Anna Norhammar, Maria Eriksson Svensson, Stefan Gustafsson
Publikováno v:
BMJ Open, Vol 14, Iss 4 (2024)
Objectives Identify the windows of opportunity for the diagnosis of chronic kidney disease (CKD) and the prevention of its adverse outcomes and quantify the potential population gains of such prevention.Design and setting Observational, population-wi
Externí odkaz:
https://doaj.org/article/497edc95af22441f9ab57b5586207ef9
Autor:
Elena Fortin, Magnus Lundin, Linda Mellbin, Anna Norhammar, Per Näsman, Stina Smetana, Peder Sörensson, Ele Ferrannini, Lars Rydén, Giulia Ferrannini
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Empagliflozin reduces the risk of cardiovascular disease (CVD) in patients with type 2 diabetes (T2DM) and high cardiovascular risk via mechanisms which have not been fully explained. The mechanisms of such benefit have not been f
Externí odkaz:
https://doaj.org/article/bc8090c54dee4cd4b7a30993c322c26d
Autor:
Ritsinger, Viveca, Hagström, Emil, Hambraeus, Kristina, James, Stefan, Jernberg, Tomas, Lagerqvist, Bo, Leosdottir, Margrét, Lundman, Pia, Pernow, John, Östlund, Ollie, Norhammar, Anna
Publikováno v:
In Journal of Diabetes and Its Complications October 2023 37(10)
Autor:
Robin Kristófi, Johan Bodegard, Viveca Ritsinger, Marcus Thuresson, David Nathanson, Thomas Nyström, Anna Norhammar, Jan W. Eriksson
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background The risk of severe coronavirus disease 2019 (COVID-19) is increased in people with diabetes, but effects of diabetes type and other risk factors remain incompletely characterized. We studied this in a Swedish cohort of hospitalize
Externí odkaz:
https://doaj.org/article/61935048b5c849f9af4bf5454f20c99f
Autor:
Giuseppe M.C. Rosano, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Yuri Lopatin, Fin Gustafsson, Antoni Bayes‐Genis, Tiny Jaarsma, Magdy Abdelhamid, Arantxa Gonzalez Miqueo, Massimo Piepoli, Carlo G. Tocchetti, Arsen D. Ristić, Ewa Jankowska, Brenda Moura, Loreena Hill, Gerasimos Filippatos, Marco Metra, Davor Milicic, Thomas Thum, Ovidiu Chioncel, Tuvia Ben Gal, Lars H. Lund, Dimitrios Farmakis, Wilfried Mullens, Stamatis Adamopoulos, Michael Bohm, Anna Norhammar, Andreas Bollmann, Amitava Banerjee, Aldo P. Maggioni, Adriaan Voors, Alain Cohen Solal, Andrew J.S. Coats
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2767-2778 (2022)
Abstract Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and mor
Externí odkaz:
https://doaj.org/article/d082594880a44faf89c82613271970d4